| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 20.352 | 21.121 | 20.729 | 9.609 | 0 | 15.174 | 22.096 | 27.537 | 29.043 |
| Total Income - EUR | - | 20.352 | 21.121 | 20.729 | 9.609 | 0 | 15.174 | 22.096 | 27.537 | 29.043 |
| Total Expenses - EUR | - | 4.508 | 14.035 | 11.343 | 21.434 | 4.841 | 19.351 | 17.225 | 12.192 | 17.827 |
| Gross Profit/Loss - EUR | - | 15.844 | 7.086 | 9.386 | -11.825 | -4.841 | -4.177 | 4.871 | 15.345 | 11.216 |
| Net Profit/Loss - EUR | - | 15.233 | 5.749 | 8.907 | -11.921 | -4.841 | -4.623 | 4.318 | 15.100 | 10.362 |
| Employees | - | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Streza Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 26.052 | 22.399 | 20.190 | 16.535 | 13.019 | 9.599 | 6.488 | 3.337 | 205 |
| Current Assets | - | 10.294 | 12.198 | 20.945 | 10.034 | 9.350 | 3.470 | 6.834 | 13.011 | 13.885 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 3.626 | 9.739 | 8.939 | 9.708 | 7.352 | 1.373 | 6.038 | 6.882 | 7.999 |
| Cash | - | 6.668 | 2.459 | 12.006 | 326 | 1.998 | 2.097 | 797 | 6.129 | 5.887 |
| Shareholders Funds | - | 15.278 | 20.768 | 29.293 | 16.666 | 11.509 | 1.779 | 4.224 | 15.141 | 10.411 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 21.068 | 13.829 | 11.841 | 9.903 | 10.860 | 11.291 | 9.098 | 1.208 | 3.679 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Streza Medical Srl